Application of prioritization approaches to optimize environmental monitoring and testing of pharmaceuticals

References

• Alder, A. C., C. Schaffner, M. Majewsky, J. Klasmeier, and K. Fenner. 2010. Fatw of β-blocker human pharmaceuticals in surface water: Comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Research 44:936–48. doi:10.1016/j.watres.2009.10.002.
   PubMed Web of Science ®Google Scholar
• Al-Khazrajy, O. S. A., and A. B. A. Boxall. 2016. Risk-based prioritization of pharmaceuticals in the natural environment in Iraq. Environment Sciences Pollution Researcher 23:15712–26. doi:10.1007/s11356-016-6679-0.
   PubMed Web of Science ®Google Scholar
• Ankley, G. T., R. S. Bennett, R. J. Erickson, D. J. Hoff, M. W. Hornung, R. D. Johnson, D. R. Mount, C. L. Russom, P. K. Schmeider, J. A. Serrano, J. E. Tietge, and D. L. Villeneuve. 2010. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environmental Toxicology and Chemistry 29:730–41. doi:10.1002/etc.34.
   PubMed Web of Science ®Google Scholar
• Ankley, G. T., B. W. Brooks, D. B. Huggett, and J. P. Sumpter. 2007. Repeating history: Pharmaceuticals in the environment. Environmental Science & Technology 41:8211–17. doi:10.1021/es072658j.
   PubMed Web of Science ®Google Scholar
• Asano, T., A. D. Levine, H. Leverenz, R. Tsuchihashi, and G. Tchobanoglous. 2007. Water reuse: Issues, technologies, and applications. New York: McGraw-Hill.
   Google Scholar
• Aubakirova, B., R. Beisenova, and A. B. Boxall. 2017. Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan. Integrative Environment Assessment Manage 5:832–39. doi:10.1002/ieam.1895.
   Google Scholar
• aus der Beek, T., F.-A. Weber, A. Bergmann, S. Hickmann, I. Ebert, A. Hein, and A. Küster. 2016. Pharmaceuticals in the environment-global occurrences and perspectives. Environmental Toxicology and Chemistry 35:823–35. doi:10.1002/etc.3339.
   PubMed Web of Science ®Google Scholar
• Batt, A. L., E. T. Furlong, H. E. Mash, S. T. Glassmeyer, and D. W. Kolpin. 2017. The importance of quality control in validating concentrations of contaminants of emerging concern in source and treated drinking water samples. The Science of the Total Environment 579:1618–28. doi:10.1016/j.scitotenv.2016.02.127.
   PubMed Web of Science ®Google Scholar
• Bergheim, M., R. Gminski, A. B. Spangenberg, C. Malgorzata, D. Ebiak, D. A. Bü, V. Mersch-Sundermann, K. Kü, and R. Gier. 2014. Recalcitrant pharmaceuticals in the aquatic environment: A comparative screening study of their occurrence, formation of photo-transformation products and their in vitro toxicity. Environmental Chemistry 11:431–44. doi:10.1071/EN13218.
   Web of Science ®Google Scholar
• Berninger, J. P., C. A. Lalone, D. L. Villeneuve, and G. T. Ankley. 2016. Prioritization of pharmaceuticals for potential environmental hazard through leveraging a large-scale mammalian pharmacological dataset. Environmental Toxicology and Chemistry 35:1007–20. doi:10.1002/etc.2965.
   PubMed Web of Science ®Google Scholar
• Berthod, L., D. C. Whitley, G. Roberts, A. Sharpe, R. Greenwood, and G. A. Mills. 2017. Quantitative structure-property relationships for predicting sorption of pharmaceuticals to sewage sludge during waste water treatment processes. The Science of the Total Environment 579:1512–20. doi:10.1016/j.scitotenv.2016.11.156.
   PubMed Web of Science ®Google Scholar
• Besse, J.-P., and J. Garric. 2010. Environmental risk assessment and prioritisation strategies for human pharmaceuticals, review and discussion. In Pharmaceuticals in the environment: Current knowledge and need assessment to reduce presence and impact, Ed. B. Roig, 137–68. London: IWA Publishing.
   Google Scholar
• Besse, J. P., C. Kausch-Barreto, and J. Garric. 2008. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: Application to the French situation and preliminary prioritisation. Human Ecology Risk Assessment 14:665–95. doi:10.1080/10807030802235078.
   Web of Science ®Google Scholar
• Besse, J. P., J. F. Latour, and J. Garric. 2012. Anticancer drugs in surface waters. What can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environment International 39:73–86. doi:10.1016/j.envint.2011.10.002.
   PubMed Web of Science ®Google Scholar
• BIO Intelligence Service, 2013. Study on the environmental risks of medicinal products, Final Report prepared for Executive Agency for Health and Consumers.
   Google Scholar
• Booker, V., C. Halsall, N. Llewellyn, A. Johnson, and R. Williams. 2014. Prioritising anticancer drugs for environmental monitoring and risk assessment purposes. Sciences Total Environment 473–474:159–70. doi:10.1016/j.scitotenv.2013.11.145.
   PubMed Web of Science ®Google Scholar
• Bouissou-Schurtz, C., P. Houeto, M. Guerbet, M. Bachelot, C. Casellas, A. C. Mauclaire, P. Panetier, C. Delval, and D. Masset. 2014. Ecological risk assessment of the presence of pharmaceutical residues in a French national water survey. Regulatory Toxicogical Pharmacology 69:296–303. doi:10.1016/j.yrtph.2014.04.006.
   PubMed Web of Science ®Google Scholar
• Boxall, A. B. A., M. A. Rudd, B. W. Brooks, D. J. Caldwell, K. Choi, S. Hickmann, E. Innes, T. Verslycke, G. T. Ankley, K. F. Beaszley, S. E. Belanger, J. P. Berninger, P. Carriquiriborde, A. Coorsw, P. C. DeLeo, S. D. Dyer, J. F. Ericson, F. Gagne, J. P. Giesy, T. Gouin, L. Hallstrom, M. V. Karlson, D. G. J. Larsson, J. M. Lazorchak, F. Mastrocco, A. McLauglin, M. E. McMaster, R. D. Meyeerhyoff, R. Moore, J. L. Parrott, J. R. Snape, R. Murray-Smith, M. R. Servos, P. K. Sibley, J. O. Straub, N. D. Szabo, E. Topp, G. R. Tetrault, V. L. Trudeau, and G. van der Kraak. 2012. Pharmaceuticals and personal care products in the environment: What are the big questions? Environment Health Perspectives 120:1221–29. doi:10.1289/ehp.1104477.
   PubMed Web of Science ®Google Scholar
• Brausch, J. M., K. A. Connors, B. W. Brooks, and G. M. Rand. 2012. Human pharmaceuticals in the aquatic environment: A review of recent toxicological studies and considerations for toxicity testing. Reviews Environment Contamination Toxicogical 218:1–99.
   PubMed Web of Science ®Google Scholar
• Brodin, T., J. Nording, A. Lagesson, J. Klaminder, G. Hellstrom, B. Christensen, and J. Fick. 2017. Environmental relevant levels of a benzodiazepine (oxazepam) alters important traits in a common planktivorous fish(Rutilus rutilus). Journal of Toxicology and Environmental Health. Part A 80:963–70. doi:10.1080/15287394.2017.1352214.
   PubMed Web of Science ®Google Scholar
• Burns, E. E., L. J. Carter, D. W. Kolpin, J. Thomas-Oates, and A. B. A. Boxall. 2018. Temporal and spatial variation in pharmaceuitcal concentrations in an urban river system. Water Research 137:72–85. doi:10.1016/j.watres.2018.02.066.
   PubMed Web of Science ®Google Scholar
• Burns, E. E., J. Thomas-Oates, D. W. Kolpin, E. T. Furlong, and A. B. A. Boxall. 2017. Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose? Environmental Toxicology and Chemistry 36:2823–32. doi:10.1002/etc.3842.
   PubMed Web of Science ®Google Scholar
• Caldwell, D. J., F. Mastrocco, L. Margiotta-Casaluci, and B. W. Brooks. 2014. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research. Chemosphere 115:4–12. doi:10.1016/j.chemosphere.2014.01.021.
   PubMed Web of Science ®Google Scholar
• Cardoso, O., J.-M. Porcher, and W. Sanchez. 2014. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: Review of evidence and need for knowledge. Chemosphere 115:20–30. doi:10.1016/j.chemosphere.2014.02.004.
   PubMed Web of Science ®Google Scholar
• Casado-Martinez, M., M. Wildi, B. Ferrari, and I. Werner. 2017. Prioritization of substances for national ambient monitoring of sediment in Switzerland. Environment Sciences Pollution Researcher 25:3127–38. doi:10.1007/s11356-017-9082-6.
   PubMed Web of Science ®Google Scholar
• Castiglioni, S., R. Bagnati, R. Fanelli, F. Pomati, D. Calamari, and E. Zuccato. 2006. Removal of pharmaceuticals in sewage treatment plants in Italy. Environmental Science & Technology 40:357–63. doi:10.1021/es050991m.
   PubMed Web of Science ®Google Scholar
• Celiz, M. D., J. Tso, and D. S. Aga. 2009. Pharmaceutical metabolites in the environment: Analytical challenges and ecological risks. Environmental Toxicology and Chemistry 28:2473–84. doi:10.1897/09-173.1.
   PubMed Web of Science ®Google Scholar
• Chefetz, B., T. Mualem, and J. Ben-Ari. 2008. Sorption and mobility of pharmaceutical compounds in soil irrigated with reclaimed wastewater. Chemosphere 73:1335–43. doi:10.1016/j.chemosphere.2008.06.070.
   PubMed Web of Science ®Google Scholar
• Christen, V., S. Hickmann, B. Rechenberg, and K. Fent. 2010. Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action. Aquatic Toxicology 96:167–81. doi:10.1016/j.aquatox.2009.11.021.
   PubMed Web of Science ®Google Scholar
• Cunningham, V. L., S. P. Binks, and M. J. Olson. 2009. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regulatory Toxicogical Pharmacology 53:39–45. doi:10.1016/j.yrtph.2008.10.006.
   PubMed Web of Science ®Google Scholar
• Cuthbert, R. J., M. A. Taggart, V. Prakash, S. S. Chakraborty, P. Deori, T. Galligan, M. Kulkarni, S. Ranade, M. Saini, A. K. Sharma, et al. 2014. Avian scavengers and the threat from veterinary pharmaceuticals. Phil Transactions R Social B Biologic Sciences 369:20130574. doi:10.1098/rstb.2013.0574.
   PubMed Web of Science ®Google Scholar
• Dalkmann, P., M. Broszat, C. Siebe, E. Willaschek, T. Sakinc, J. Huebner, W. Amelung, E. Grohmann, and J. Siemens. 2012. Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in Central Mexico. PLoS ONE 7:e45397. doi:10.1371/journal.pone.0045397.
   PubMed Web of Science ®Google Scholar
• Datapharm Communications Limited. 2017. The Electronic Medicines Compendium (eMC). Medicines. Accessed August 21, 2017. https://www.medicines.org.uk/emc/browse-documents.
   Google Scholar
• Daughton, C. G. 2014. The Matthew effect and widely prescribed pharmaceuticals lacking environmental monitoring: Case study of an exposure-assessment vulnerability. The Science of the Total Environment 466–467:315–25. doi:10.1016/j.scitotenv.2013.06.111.
   PubMed Web of Science ®Google Scholar
• De Carvalho, N., R. L. Ceriani, A. Ippolito, and T. Lettieri. 2015. JRC technical report: Development of the first watch list under the environmental quality standards directive. EUR 27142. Publications Office of the European Union. Accessed November 3, 2017. https://ec.europa.eu/jrc/en/publication/eur-scientific-and-technical-research-reports/development-first-watch-list-under-environmental-quality-standards-directive.
   Google Scholar
• de García, O. S., G. P. Pinto, P. A. García-Encina, and R. I. Mata. 2013. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: An application to the Spanish case. Journal of Environmental Management 129:384–97. doi:10.1016/j.jenvman.2013.06.035.
   PubMed Web of Science ®Google Scholar
• de Haas, E. M., T. Eikelboom, and T. Bouwman. 2011. Internal and external validation of the long-term QSARs for neutral organics to fish from ECOSAR. SAR QSAR Environment Researcher 22:545–59. doi:10.1080/1062936X.2011.569949.
   PubMed Web of Science ®Google Scholar
• Diamond, J. M., H. A. Latimer, K. R. Munkittrick, K. W. Thornton, S. M. Bartell, and K. A. Kidd. 2011. Prioritizing contaminants of emerging concern for ecological screening assessments. Environmental Toxicology and Chemistry 30:2385–94. doi:10.1002/etc.667.
   PubMed Web of Science ®Google Scholar
• Dong, Z., D. B. Senn, R. E. Moran, and J. P. Shine. 2013. Prioritizing environmental risk of prescription pharmaceuticals. Regulatory Toxicogical Pharmacology 65:60–67. doi:10.1016/j.yrtph.2012.07.003.
   PubMed Web of Science ®Google Scholar
• Environmental Health Analysis Centre under contract to the Office of Chemical Safety and Pollution Prevention. 2016. PBT profiler, A component of OPPT’S P2 framework: Assessing chemicals in the absence of data. U.S. Environmental Protection Agency. Accessed November 3, 2017. http://www.pbtprofiler.net/.
   Google Scholar
• European Medicines Agency. 2017. Human medicines: European public assessment reports. Accessed August 21, 2017. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d125.
   Google Scholar
• European Medicines Agency (EMA). 2006. Pre-Authorisation evaluation of medicines for human use: Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00. Committee for Medicinal Products for Human Use, London, UK. Accessed November 3, 2017. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500003978.pdf.
   Google Scholar
• Fàbrega, F., M. Marquès, A. Ginebreda, M. Kuzmanovic, D. Barceló, M. Schuhmacher, J. L. Domingo, and M. Nadal. 2013. Integrated risk index of chemical aquatic pollution (IRICAP): Case studies in Iberian rivers. Journal of Hazardous Materials 263:187–96. doi:10.1016/j.jhazmat.2013.06.006.
   PubMed Web of Science ®Google Scholar
• Feijtel, T., G. Boeije, M. Matthies, A. Young, G. Morris, C. Gandolfi, B. Hansen, K. Fox, M. Holt, V. Koch, R. Schroder, et al. 1997. Development of a geography-referenced regional exposure assessment tool for European rivers – Great-ER: Contribution to GREAT-ER #1. Chemosphere 34:2351–73. doi:10.1016/S0045-6535(97)00048-9.
   Web of Science ®Google Scholar
• Fick, J., R. H. Lindberg, M. Tysklind, and D. G. J. Larsson. 2010. Predicted critical environmental concentrations for 500 pharmaceuticals. Regulatory Toxicogical Pharmacology 58:516–23. doi:10.1016/j.yrtph.2010.08.025.
   PubMed Web of Science ®Google Scholar
• Franklin, A. M., C. F. Williams, D. M. Andrews, E. E. Woodward, and J. E. Watson. 2016. Uptake of three antibiotics and an antiepileptic drug by wheat crops spray irrigated with wastewater treatment plant effluent. Journal of Environmental Quality 45:546. doi:10.2134/jeq2015.05.0257.
   PubMed Web of Science ®Google Scholar
• Furuhagen, S., A. Fuchs, E. Lundström Belleza, M. Breitholtz, and E. Gorokhova. 2014. Are pharmaceuticals with evolutionary conserved molecular drug targets more potent to cause toxic effects in non-target organisms? PloS One 9:e105028. doi:10.1371/journal.pone.0105028.
   PubMed Web of Science ®Google Scholar
• Gardner, M., V. Jones, S. Comber, M. D. Scrimshaw, T. Coello-Garcia, E. Cartmell, J. Lester, and B. Ellor. 2013. Performance of UK wastewater treatment works with respect to trace contaminants. The Science of the Total Environment 456–457:359–69. doi:10.1016/j.scitotenv.2013.03.088.
   PubMed Web of Science ®Google Scholar
• Gaw, S., and B. W. Brooks. 2016. Changing tides: Adaptive monitoring, assessment, and management of pharmaceutical hazards in the environment through time. Environmental Toxicology and Chemistry 35:1037–42. doi:10.1002/etc.3264.
   PubMed Web of Science ®Google Scholar
• Götz, C. W., C. Stamm, K. Fenner, H. Singer, M. Schärer, and J. Hollender. 2010. Targeting aquatic microcontaminants for monitoring: Exposure categorization and application to the Swiss situation. Environment Sciences Pollution Researcher 17:341–54. doi:10.1007/s11356-009-0167-8.
   PubMed Web of Science ®Google Scholar
• Grabicova, K., R. Grabic, M. Blaha, V. Kumar, D. Cerveny, G. Fedorova, and T. Randak. 2015. Presence of pharmaceuticals in benthic fauna living in a small stream affected by effluent from a municipal sewage treatment plant. Water Research 72:145–53. doi:10.1016/j.watres.2014.09.018.
   PubMed Web of Science ®Google Scholar
• Guo, J., C. J. Sinclair, K. Selby, and A. B. A. Boxall. 2016. Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment. Environmental Toxicology and Chemistry 35:1550–59. doi:10.1002/etc.3319.
   PubMed Web of Science ®Google Scholar
• Henze, M., and Y. Comeau. 2008. Biological wastewater treatment principles, modelling and design, Ed. M. Henze, M. C. M. Van Loosdrecht, G. A. Ekama, and D. Brdjanovic. London: IWA Publishing.
   Google Scholar
• Heye, K., D. Becker, C. Lütke Eversloh, V. Durmaz, T. A. Ternes, M. Oetken, and J. Oehlmann. 2016. Effects of carbamazepine and two of its metabolites on the non-biting midge Chironomus Riparius in a sediment full life cycle toxicity test. Water Research 98:19–27. doi:10.1016/j.watres.2016.03.071.
   PubMed Web of Science ®Google Scholar
• Hollander, A., F. Sauter, H. den Hollander, M. Huijbregts, A. Ragas, and D. van de Meent. 2007. Spatial variance in multimedia mass balance models: Comparison of LOTOS–EUROS and SimpleBox for PCB-153. Chemosphere 68:1318–26. doi:10.1016/j.chemosphere.2007.01.035.
   PubMed Web of Science ®Google Scholar
• Howard, P. H., and D. C. G. Muir. 2011. Identifying new persistent and bioaccumulative organics among chemicals in commerce II: Pharmaceuticals. Environmental Science & Technology 45:6938–46. doi:10.1021/es201196x.
   PubMed Web of Science ®Google Scholar
• Huber, S., M. Remberger, L. Kaj, M. Schlabach, H. Ó. Jörundsdóttir, J. Vester, M. Arnórsson, I. Mortensen, R. Schwartson, and M. Dam. 2016. A first screening and risk assessment of pharmaceuticals and additives in personal care products in waste water, sludge, recipient water and sediment from Faroe Islands, Iceland and Greenland. The Science of the Total Environment 562:13–25. doi:10.1016/j.scitotenv.2016.03.063.
   PubMed Web of Science ®Google Scholar
• Huggett, D. B., J. C. Cook, J. F. Ericson, and R. T. Williams. 2003. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Human Ecology Risk Assessment 9:1789–99. doi:10.1080/714044797.
   Web of Science ®Google Scholar
• Hulzebos, E. M., and R. Posthumus. 2003. (Q)SARs: Gatekeepers against risk of chemicals? SAR QSAR Environment Researcher 14:285–316. doi:10.1080/1062936032000101510.
   PubMed Web of Science ®Google Scholar
• Itzel, F., L. Gehrmann, H. Bielak, P. Ebersbach, A. Boergers, H. Herbst, C. Maus, A. Simon, E. Dopp, M. Hammers-Wirtz, T. C. Schmidt, and J. Tuerk. 2017. Investigation of full-scale ozonation at a municipal wastewater treatment plant using a toxicity-based evaluation concept. Journal of Toxicology and Environmental Health. Part A 80:1242–58. doi:10.1080/15287394.2017.1369663.
   PubMed Web of Science ®Google Scholar
• Jelic, A., M. Gros, A. Ginebreda, R. Cespedes-Sánchez, F. Ventura, M. Petrovic, and D. Barcelo. 2011. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Research 45:1165–76. doi:10.1016/j.watres.2010.11.010.
   PubMed Web of Science ®Google Scholar
• Jones, O. A. H., N. Voulvoulis, and J. N. Lester. 2002. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 36:5013–22. doi:10.1016/S0043-1354(02)00227-0.
   PubMed Web of Science ®Google Scholar
• Karlsson, M. V., S. Marshall, T. Gouin, and A. B. A. Boxall. 2016. Routes of uptake of diclofenac, fluoxetine, and triclosan into sediment-dwelling worms. Environmental Toxicology and Chemistry 35:836–42. doi:10.1002/etc.3020.
   PubMed Web of Science ®Google Scholar
• Keller, V. D. J., R. J. Williams, C. Lofthouse, and A. C. Johnson. 2014. Worldwide estimation of river concentrations of any chemical originating from sewage-treatment plants using dilution factors. Environmental Toxicology and Chemistry 33:447–52. doi:10.1002/etc.2441.
   PubMed Web of Science ®Google Scholar
• Kim, M. H., J. Park, Y. H. Kim, and K. Choi. 2006. Prioritising human use antibiotics for environmental health management and estimating their environmental concentrations in Korean waterway. Korean Journal Environment Health Sciences 32:462–68.
   Google Scholar
• Kinney, C. A., E. T. Furlong, D. W. Kolpin, M. R. Burkhardt, S. D. Zaugg, S. L. Werner, J. P. Bossio, and M. J. Benotti. 2008. Bioaccumulation of pharmaceutical and other anthropogenic waste indicators in earthworms from agricultural soil amended with biosolid or swine manure. Environmental Science & Technology 42:1863–70. doi:10.1021/es702304c.
   PubMed Web of Science ®Google Scholar
• Kinney, C. A., E. T. Furlong, S. L. Werner, and J. D. Cahill. 2006a. Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environmental Toxicology and Chemistry 25:317–26. doi:10.1897/05-187R.1.
   PubMed Web of Science ®Google Scholar
• Kinney, C. A., E. T. Furlong, S. D. Zaugg, M. R. Burkhardt, S. L. Werner, J. D. Cahill, and G. R. Jorgensen. 2006b. Survey of organic wastewater contaminants in biosolids destined for land application. Environmental Science & Technology 40:7207–15. doi:10.1021/es0603406.
   PubMed Web of Science ®Google Scholar
• Kools, S. A. E., J. F. Moltmann, and T. Knacker. 2008. Estimating the use of veterinary medicines in the European Union. Regulatory Toxicogical Pharmacology 50:59–65. doi:10.1016/j.yrtph.2007.06.003.
   PubMed Web of Science ®Google Scholar
• Kostich, M. S., and J. M. Lazorchak. 2008. Risks to aquatic organisms posed by human pharmaceutical use. The Science of the Total Environment 389:329–39. doi:10.1016/j.scitotenv.2007.09.008.
   PubMed Web of Science ®Google Scholar
• Kumar, A., and I. Xagoraraki. 2010. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system. The Science of the Total Environment 408:5972–89. doi:10.1016/j.scitotenv.2010.08.048.
   PubMed Web of Science ®Google Scholar
• Küster, A., and N. Adler. 2014. Pharmaceuticals in the environment: Scientific evidence of risks and its regulation. Phil Transactions R Social B Biologic Sciences 369:20130587. doi:10.1098/rstb.2013.0587.
   PubMed Web of Science ®Google Scholar
• Lalone, C. A., J. P. Berninger, D. L. Villeneuve, and G. T. Ankley. 2014. Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms. Phil Transactions R Social B Biologic Sciences 369:20140022. doi:10.1098/rstb.2014.0022.
   PubMed Web of Science ®Google Scholar
• Larsson, D. G. J. 2014. Pollution from drug manufacturing: Review and perspectives. Phil Transactions R Social B Biologic Sciences 369:20130571. doi:10.1098/rstb.2013.0571.
   PubMed Web of Science ®Google Scholar
• Le Corre, K. S., C. Ort, D. Kateley, B. Allen, B. I. Escher, and J. Keller. 2012. Consumption-based approach for assessing the contribution of hospitals towards the load of pharmaceutical residues in municipal wastewater. Environment International 45:99–111. doi:10.1016/j.envint.2012.03.008.
   PubMed Web of Science ®Google Scholar
• Lees, K., M. Fitzsimons, J. Snape, A. Tappin, and S. Comber. 2016. Pharmaceuticals in soils of lower income countries: Physico-chemical fate and risks from wastewater irrigation. Environment International 94:712–23. doi:10.1016/j.envint.2016.06.018.
   PubMed Web of Science ®Google Scholar
• Leung, H. W., L. Jin, S. Wei, M. M. P. Tsui, B. Zhou, L. Jiao, P. C. Cheung, Y. K. Chun, M. B. Murphy, and P. K. S. Lam. 2013. Pharmaceuticals in tap water: Human health risk assessment and proposed monitoring framework in China. Environment Health Perspectives 7:839–46. doi:10.1289/ehp.1206244.
   Google Scholar
• Li, Z., M. Li, X. Liu, Y. Ma, and M. Wu. 2014. Identification of priority organic compounds in groundwater recharge of China. The Science of the Total Environment 493:481–86. doi:10.1016/j.scitotenv.2014.06.005.
   PubMed Web of Science ®Google Scholar
• Lienert, J., K. Güdel, and B. I. Escher. 2007. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environmental Science & Technology 12:4471–78. doi:10.1021/es0627693.
   Google Scholar
• Lübbert, C., C. Baars, A. Dayakar, N. Lippmann, A. C. Rodloff, M. Kinzig, and F. Sörgel. 2017. Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens. Infection 45:479–91. doi:10.1007/s15010-017-1007-2.
   PubMed Web of Science ®Google Scholar
• Luo, Y., W. Guo, H. H. Ngo, L. D. Nghiem, F. I. Hai, J. Zhang, S. Liang, and X. C. Wang. 2014. A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. The Science of the Total Environment 473–474:619–41. doi:10.1016/j.scitotenv.2013.12.065.
   PubMed Web of Science ®Google Scholar
• Malchi, T., Y. Maor, G. Tadmor, M. Shenker, and B. Chefetz. 2014. Irrigation of root vegetables with treated wastewater: Evaluating uptake of pharmaceuticals and the associated human health risks. Environmental Science & Technology 48:9325–33. doi:10.1021/es5017894.
   PubMed Web of Science ®Google Scholar
• Margiotta-Casaluci, L., S. F. Owen, R. I. Cumming, A. de Polo, M. J. Winter, G. H. Panter, M. Rand-Weaver, and J. P. Sumpter. 2014. Quantitative cross-species extrapolation between humans and fish: The case of the anti-depressant fluoxetine. PLoS One 10:e110467. doi:10.1371/journal.pone.0110467.
   Google Scholar
• Masoner, J. R., D. W. Kolpin, E. T. Furlong, I. M. Cozzarelli, and J. L. Gray. 2016. Landfill leachate as a mirror of today’s disposable society: Pharmaceuticals and other contaminants of emerging concern in final leachate from landfills in the conterminous United States. Environmental Toxicology and Chemistry 4:906–18. doi:10.1002/etc.3219.
   Google Scholar
• Mennigen, J. A., P. Stroud, J. M. Zamora, T. W. Moon, and V. L. Trudeau. 2011. Pharmaceuticals as neuroendocrine disruptors: Lesson learned from fish on prozac. Journal Toxicogical Environment Health B 14:387–412. doi:10.1080/10937404.2011.578559.
   PubMed Web of Science ®Google Scholar
• Miller, T. H., G. L. McEneff, R. J. Brown, S. F. Owen, N. R. Bury, and L. P. Barron. 2015. Pharmaceuticals in the freshwater invertebrate, Gammarus Pulex, determined using pulverised liquid extraction, solid phase extraction and liquid chromatography–Tandem mass spectrometry. The Science of the Total Environment 511:153–60. doi:10.1016/j.scitotenv.2014.12.034.
   PubMed Web of Science ®Google Scholar
• MistraPharma, 2018. WikiPharma Database. Accessed January 4, 2018. http://www.wikipharma.org/welcome.asp.
   Google Scholar
• Mohapatra, D. P., M. Cledón, S. K. Brar, and R. Y. Surampalli. 2016. Application of wastewater and biosolids in soil: Occurrence and fate of emerging contaminants. Water, Air, and Soil Pollution 227:77. doi:10.1007/s11270-016-2768-4.
   Web of Science ®Google Scholar
• Morais, S. A., C. Delerue-Matos, and X. Gabarrell. 2014. An uncertainty and sensitivity analysis applied to the prioritisation of pharmaceuticals as surface water contaminants from wastewater treatment plant direct emissions. The Science of the Total Environment 490:342–50. doi:10.1016/j.scitotenv.2014.04.082.
   PubMed Web of Science ®Google Scholar
• Mottaleb, M. A., C. Stowe, D. R. Johnson, M. J. Meziani, and M. A. Mottaleb. 2016. Pharmaceuticals in grocery market fish fillets by gas chromatography–Mass spectrometry. Food Chemistry 190:529–36. doi:10.1016/j.foodchem.2015.06.003.
   PubMed Web of Science ®Google Scholar
• Murray, K. E., S. M. Thomas, and A. A. Bodour. 2010. Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. Environmental Pollution 12:3462–71. doi:10.1016/j.envpol.2010.08.009.
   Google Scholar
• Murray-Smith, R. J., V. T. Coombe, M. H. Grönlund, F. Waern, and J. A. Baird. 2012. Managing emissions of active pharmaceutical ingredients from manufacturing facilities: An environmental quality standard approach. Integrative Environment Assessment Manage 8:320–30. doi:10.1002/ieam.1268.
   PubMedGoogle Scholar
• Niemuth, N. J., and R. D. Klaper. 2016. On the unexpected reproductive impacts of metformin: A need for support and new directions for the evaluation of the impacts of pharmaceuticals in the environment. Chemosphere 165:570–74. doi:10.1016/j.chemosphere.2016.08.048.
   PubMed Web of Science ®Google Scholar
• Oaks, J. L., M. Gilbert, M. Z. Virani, R. T. Watson, C. U. Meteyer, B. A. Rideout, H. L. Shivaprasad, S. Ahmed, M. J. I. Chaudhry, M. Arshad, S. Mahmood, A. Ali, and A. A. Khan. 2004. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630–33. doi:10.1038/nature02317.
   PubMed Web of Science ®Google Scholar
• Obach, R. S. 2013. Pharmacologically active drug metabolites: Impact on drug discovery and pharmacotherapy. Pharmacological Reviews 65:578–640. doi:10.1124/pr.111.005439.
   PubMed Web of Science ®Google Scholar
• Oldenkamp, R., M. A. J. Huijbregts, A. Hollander, A. Versporten, H. Goossens, and A. M. J. Ragas. 2013. Spatially explicit prioritization of human antibiotics and antineoplastics in Europe. Environment International 51:13–26. doi:10.1016/j.envint.2012.09.010.
   PubMed Web of Science ®Google Scholar
• Oldenkamp, R., M. A. J. Huijbregts, and A. M. J. Ragas. 2016. The influence of uncertainty and location-specific conditions on the environmental prioritisation of human pharmaceuticals in Europe. Environment International 91:301–11. doi:10.1016/j.envint.2016.01.025.
   PubMed Web of Science ®Google Scholar
• Olsen, L., J. F. Valder, J. M. Carter, and J. S. Zogorski. 2013. Prioritization of constituents for national- and region-scale ambient monitoring of water and sediment in the United States. Scientific Investigations Report 2012-5218. United States Geological Survey. Accessed November 3, 2017. https://pubs.er.usgs.gov/publication/sir20125218.
   Google Scholar
• Pan, B., P. Ning, and B. Xing. 2009. Part V—Sorption of pharmaceuticals and personal care products. Environment Sciences Pollution Researcher 16:106–16. doi:10.1007/s11356-008-0052-x.
   PubMed Web of Science ®Google Scholar
• Patel, A., G. H. Panter, H. T. Trollope, Y. C. Glennon, S. F. Owen, J. P. Sumpter, and M. Rand-Weaver. 2016. Testing the “read-across hypothesis” by investigating the effects of ibuprofen on fish. Chemosphere 163:592–600. doi:10.1016/j.chemosphere.2016.08.041.
   PubMed Web of Science ®Google Scholar
• Paz, A., G. Tadmor, T. Malchi, J. Blotevogel, T. Borch, T. Polubesova, and B. Chefetz. 2016. Fate of carbamazepine, its metabolites, and lamotrigine in soils irrigated with reclaimed wastewater: Sorption, leaching and plant uptake. Chemosphere 160:22–29. doi:10.1016/j.chemosphere.2016.06.048.
   PubMed Web of Science ®Google Scholar
• Pedrero, F., I. Kalavrouziotis, J. J. Alarcón, P. Koukoulakis, and T. Asano. 2010. Use of treated municipal wastewater in irrigated agriculture—Review of some practices in Spain and Greece. Agricultural Water Manage 97:1233–41. doi:10.1016/j.agwat.2010.03.003.
   Web of Science ®Google Scholar
• Perazzolo, C., B. Morasch, T. Kohn, A. Magnet, D. Thonney, and N. Chèvre. 2010. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: Priority list for environmental risk assessment of pharmaceuticals. Environmental Toxicology and Chemistry 29:1649–57.
   PubMed Web of Science ®Google Scholar
• Pereira, A. M. P. T., L. J. G. Silva, C. M. Lino, L. M. Meisel, and A. Pena. 2016. Assessing environmental risk of pharmaceuticals in Portugal: An approach for the selection of the Portuguese monitoring stations in line with Directive 2013/39/EU. Chemosphere 144:2507–15. doi:10.1016/j.chemosphere.2015.10.100.
   PubMed Web of Science ®Google Scholar
• Pereira, A. M. P. T., L. J. G. Silva, C. M. Lino, L. M. Meisel, and A. Pena. 2017. A critical evaluation of different parameters for estimating pharmaceutical exposure seeking an improved environmental risk assessment. Science of the Total Environment 603–604:226–236. doi:10.1016/j.scitotenv.2017.06.022.
   PubMed Web of Science ®Google Scholar
• Phillips, P. J., A. T. Chalmers, J. L. Gray, D. W. Kolpin, W. T. Foreman, and G. R. Wall. 2012. Combined sewer overflows: An environmental source of hormones and wastewater micropollutants. Environmental Science & Technology 46:5336–43. doi:10.1021/es3001294.
   PubMed Web of Science ®Google Scholar
• Phillips, P. J., S. G. Smith, D. W. Kolpin, S. D. Zaugg, H. T. Buxton, E. T. Furlong, K. Esposito, and B. Stinson. 2010. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environmental Science & Technology 44:4910–16. doi:10.1021/es100356f.
   PubMed Web of Science ®Google Scholar
• Redshaw, C. H., W. M. Stahl-Timmins, L. E. Fleming, I. Davidson, and M. H. Depledge. 2013. Potential changes in disease patterns and pharmaceutrical use in response to climate change. Journal Toxicogical Environment Health B 16:285–320. doi:10.1080/10937404.2013.802265.
   PubMed Web of Science ®Google Scholar
• Riva, F., E. Zuccato, and S. Castiglioni. 2015. Prioritization and analysis of pharmaceuticals for human use contaminating the aquatic ecosystem in Italy. Journal Pharmaceutical Biomedical Analysis 106:71–78. doi:10.1016/j.jpba.2014.10.003.
   PubMed Web of Science ®Google Scholar
• Roos, V., L. Gunnarsson, J. Fick, D. G. J. Larsson, and C. Rudén. 2012. Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection. The Science of the Total Environment 421–422:102–10. doi:10.1016/j.scitotenv.2012.01.039.
   PubMed Web of Science ®Google Scholar
• Royal Commission on Environmental Pollution. 2011. Demographic change and the environment (Twenty-ninth Report) London UK. Accessed February 21, 2018. http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/228980/8001.pdf.
   Google Scholar
• Sanderson, H., D. J. Johnson, T. Reitsma, R. A. Brain, C. J. Wilson, and K. R. Solomon. 2004. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Reg Toxicogical Pharmacology 39:158–83. doi:10.1016/j.yrtph.2003.12.006.
   PubMed Web of Science ®Google Scholar
• Sangion, A., and P. Gramatica. 2016. Hazard of pharmaceuticals for aquatic environment: Prioritization by structural approaches and prediction of ecotoxicity. Environment International 95:131–43. doi:10.1016/j.envint.2016.08.008.
   PubMed Web of Science ®Google Scholar
• Scholz, S., and N. Klüver. 2009. Effects of endocrine disrupters on sexual, gonadal development in fish. Sexual Developments 3:136–51. doi:10.1159/000223078.
   PubMed Web of Science ®Google Scholar
• Singer, H. P., A. E. WöSsner, C. S. Mcardell, and K. Fenner. 2016. Rapid screening for exposure to “non-target” pharmaceuticals from wastewater effluents by combining HRMS-based suspect screening and exposure modelling. Environmental Science & Technology 50:6698–707. doi:10.1021/acs.est.5b03332.
   PubMed Web of Science ®Google Scholar
• Straub, J. A. 2016. Reduction in the environmental exposure of pharmaceuticals through diagnostics, Personalised Healthcare and other approaches. A mini review and discussion paper. Sustain Chemical Pharmaceutical 3:1–7. doi:10.1016/j.scp.2015.12.001.
   Web of Science ®Google Scholar
• Stuer-Lauridsen, F., M. Birkved, L. P. Hansen, H. C. Lützhøft, and B. Halling-Sørensen. 2000. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40:783–93. doi:10.1016/S0045-6535(99)00453-1.
   PubMed Web of Science ®Google Scholar
• Tanoue, R., K. Nomiyama, H. Nakamura, J.-W. Kim, T. Isobe, R. Shinohara, T. Kunisue, and S. Tanabe. 2015. Uptake and tissue distribution of pharmaceuticals and personal care products in wild fish from treated-wastewater impacted streams. Environmental Science & Technology 49:11649–58. doi:10.1021/acs.est.5b02478.
   PubMed Web of Science ®Google Scholar
• United Nations, Department of Economic and Social Affairs: Population Division. 2014. World urbanization prospects: The 2014 revision, highlights (ST/ESA/SER.A/352). New York. Accessed November 3, 2017. https://esa.un.org/unpd/wup/publications/files/wup2014-highlights.Pdf.
   Google Scholar
• United States Food and Drug Administration. 1998. Guidance for industry: Environmental assessment of human drug and biologics applications. CMC 6. Revision 1. Accessed November 3, 2017. https://www.fda.gov/downloads/Drugs/Guidances/ucm070561.pdf.
   Google Scholar
• US Environmental Protection Agency. 2015. Estimation Programs Interface Suite™ for Microsoft® Windows. United States Environmental Protection Agency, Washington, DC, USA. Accessed November 3, 2017. https://www.epa.gov/tsca-screening-tools/epi-suitetm-estimation-program-interface.
   Google Scholar
• Vasquez, M., A. Lambrianides, M. Schneider, K. Kümmerer, and D. Fatta-Kassinos. 2014. Environmental side effects of pharmaceutical cocktails: What we know and what we should know. Journal of Hazardous Materials 279:169–89. doi:10.1016/j.jhazmat.2014.06.069.
   PubMed Web of Science ®Google Scholar
• Vazquez-Roig, P., V. Andreu, C. Blasco, and Y. Picó. 2012. Risk assessment on the presence of pharmaceuticals in sediments, soils and waters of the Pego–Oliva Marshlands (Valencia, eastern Spain). The Science of the Total Environment 440:24–32. doi:10.1016/j.scitotenv.2012.08.036.
   PubMed Web of Science ®Google Scholar
• Verbruggen, B., L. Gunnarsson, E. Kristiansson, T. Österlund, S. F. Owen, J. R. Snape, and C. R. Tyler. 2018. ECOdrug: A database connecting drugs and conservation of their targets across species. Nuclear Acid Researcher 46:D930–D936. doi:10.1093/nar/gkx1024.
   PubMed Web of Science ®Google Scholar
• Verlicchi, P., M. Al Aukidy, A. Jelic, M. Petrović, and D. Barceló. 2014. Comparison of measured and predicted concentrations of selected pharmaceuticals in wastewater and surface water: A case study of a catchment area in the Po Valley (Italy). The Science of the Total Environment 470–471:844–54. doi:10.1016/j.scitotenv.2013.10.026.
   PubMed Web of Science ®Google Scholar
• Vestel, J., D. J. Caldwell, L. Constantine, V. J. D’Aco, T. Davidson, D. G. Dolan, S. P. Millard, R. Murray-Smith, N. J. Parke, J. J. Ryan, J. O. Straub, and P. Wilson. 2016. Use of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals. Environmental Toxicology and Chemistry 35:1201–12. doi:10.1002/etc.3260.
   PubMed Web of Science ®Google Scholar
• Wang, H., N. Wang, B. Wang, H. Fang, C. Fu, C. Tang, F. Jiang, Y. Zhou, G. He, Q. Zhao, Y. Chen, and Q. Jiang. 2016. Antibiotics detected in urines and adipogenesis in school children. Environment International 89:204–11. doi:10.1016/j.envint.2016.02.005.
   PubMed Web of Science ®Google Scholar
• Weatherly, L. M., and J. A. Gosse. 2017. Triclosan exposure, transformation and human health effects. Journal Toxicogical Environment Health B 20:447–69. doi:10.1080/10937404.2017.1399306.
   PubMed Web of Science ®Google Scholar
• Wennmalm, A., and B. Gunnarsson. 2005. Public health care management of water pollution with pharmaceuticals: Environmental classification and analysis of pharmaceutical residues in sewage water. Therapeutics Innovation and Regulatory Sciences 39:291–97.
   Google Scholar
• Yang, -Y.-Y., G. S. Toor, P. C. Wilson, and C. F. Williams. 2016. Septic systems as hot-spots of pollutants in the environment: Fate and mass balance of micropollutants in septic drainfields. The Science of the Total Environment 566:1535–44. doi:10.1016/j.scitotenv.2016.06.043.
   PubMed Web of Science ®Google Scholar